AT-Patch (ATP-C130/ATP-C70) vs OPTIS Mobile Next Imaging
AI Verdict
Choose AT-Patch (ATP-C130/ATP-C70) if…
Choose AT-Patch if you require extended, non-invasive ambulatory ECG monitoring for patients outside of a hospital setting. This tool is ideal for detecting intermittent arrhythmias over several days, offering patient comfort with its lightweight, shower-proof design and eliminating the need for charging or electrode replacement during the monitoring period.
View AT-Patch (ATP-C130/ATP-C70) →Choose OPTIS Mobile Next Imaging if…
Choose OPTIS Mobile Next Imaging if your cath lab needs an advanced, AI-powered intravascular imaging system to guide percutaneous coronary intervention (PCI) procedures. This system provides high-resolution OCT and coronary physiology measurements in real-time, enabling interventional cardiologists to make informed decisions and enhance procedural efficiency during complex interventions.
View OPTIS Mobile Next Imaging →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AT-Patch (ATP-C130/ATP-C70) | OPTIS Mobile Next Imaging |
|---|---|---|
| Deployment | Wearable device for patients; analysis software deployed on-premise at medical institutions. | On-premise (mobile cart system integrated into catheterization laboratories) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AT-Patch (ATP-C130/ATP-C70)Tool A prioritizes patient comfort and ease of use for extended wear, featuring a lightweight, shower-proof design that requires no charging or electrode replacement during its 14-day monitoring period. The accompanying smartphone app further enhances patient engagement and usability. While Tool B focuses on clinician workflow efficiency, Tool A's design for minimal patient intervention over a long duration gives it an edge in overall usability for its primary end-user.
Clinical Value
OPTIS Mobile Next ImagingBoth tools offer significant clinical value in their respective domains. However, Tool B provides real-time, multi-modal data (high-resolution OCT and coronary physiology) to directly guide complex percutaneous coronary intervention (PCI) procedures, impacting immediate critical decisions and potentially improving patient outcomes. Tool A offers crucial long-term diagnostic data for arrhythmia detection, but Tool B's direct impact on real-time interventional guidance is arguably more immediate and critical.
Pricing & Value
TieNeither Tool A nor Tool B provides publicly available pricing information. Without any details on cost, it is impossible to conduct a meaningful comparison of their pricing or assess their relative value proposition.
Enterprise Readiness
OPTIS Mobile Next ImagingTool B explicitly highlights 'Seamless and secure integration with cath lab IT systems and DICOM,' which are critical features for enterprise readiness within a hospital's complex IT infrastructure. While Tool A's analysis software is deployed on-premise, its specific integration capabilities with existing hospital systems are less detailed, giving Tool B an advantage in this dimension.
Innovation
OPTIS Mobile Next ImagingTool B demonstrates greater innovation by integrating high-resolution Optical Coherence Tomography (OCT) and coronary physiology measurements (RFR/FFR) onto a single platform, powered by AI for faster information display and real-time angio and OCT co-registration to guide complex PCI procedures. This multi-modal, AI-driven approach for real-time interventional guidance represents a more complex and impactful innovation compared to Tool A's advanced wearable monitoring with AI analysis.
Support & Docs
TieBoth companies appear to offer standard support resources. ATsens provides product manuals, FAQs, and contact information for AT-Patch, while Abbott Medical offers product information, technical support contacts, and educational resources for OPTIS Mobile Next Imaging. Without more specific details on the quality, breadth, or responsiveness of their support and documentation, it is not possible to distinguish a clear winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AT-Patch (ATP-C130/ATP-C70) | OPTIS Mobile Next Imaging |
|---|---|---|
| Product Name | AT-Patch (ATP-C130/ATP-C70) | OPTIS Mobile Next Imaging |
| Company | ATsens Co. | Abbott Medical |
| Primary Use Case | Wearable ECG monitor for continuous cardiac monitoring and arrhythmia detection. | AI-powered, transportable intravascular imaging system for cath labs, offering high-resolution OCT and coronary physiology measurements to guide PCI procedures. |
| Core Technology/Modality | Continuous ECG monitoring, high-performance sensor chip. | Optical Coherence Tomography (OCT) intravascular imaging, Coronary physiology measurements (RFR/FFR). |
| AI/ML Capabilities | Integrated AI-powered analysis software for enhanced arrhythmia detection; AT-Report software with AI/machine learning algorithms for ECG analysis. | High-powered processors supporting AI technology (Ultreonu2122 Software) for faster information display and workflow efficiency. |
| Target Medical Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and OPTIS Mobile Next Imaging.
Frequently Asked Questions
More Comparisons
More matchups featuring AT-Patch (ATP-C130/ATP-C70) or OPTIS Mobile Next Imaging
- AT-Patch (ATP-C130/ATP-C70) vs EchoNext
- AT-Patch (ATP-C130/ATP-C70) vs Sleepiz One+
- AT-Patch (ATP-C130/ATP-C70) vs V7 Diagnostic Ultrasound System
- AT-Patch (ATP-C130/ATP-C70) vs Study Watch with Irregular Pulse Monitor
- Lung AI vs OPTIS Mobile Next Imaging
- V7 Diagnostic Ultrasound System vs OPTIS Mobile Next Imaging